VistaGen Therapeutics, Inc.
Clinical trials sponsored by VistaGen Therapeutics, Inc., explained in plain language.
A biopharmaceutical company developing therapies for central nervous system disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Nasal spray could calm anxiety from life changes
Symptom relief CompletedThis study tested an experimental nasal spray (PH94B) to see if it can reduce anxiety in adults with adjustment disorder, a condition where stress from life events causes significant anxiety. 41 adults took the spray or a placebo four times daily for 4 weeks. The goal was to meas…
Phase 2 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Nasal spray could ease stage fright for social anxiety sufferers
Symptom relief CompletedThis Phase 3 trial tested whether a low-dose nasal spray called PH94B can quickly reduce anxiety in adults with social anxiety disorder when they have to speak in public. 224 participants used the spray or a placebo 20 minutes before a short speech and rated their distress. The s…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:19 UTC